top of page
Long-time Chief Executive Officer Ben Silbermann of Pinterest would step down, handing over the reins of the social media platform to Google...

Stock Market

Google executive to take over as a new CEO of Pinterest

Top accounting firm Ernst & Young has been slammed with a record $100 million fine from the US government...

Stock Market

Accounting firm gets 100 million fine for faulty regulations

The Indian rupee slipped into a fresh low today and extended losses against the US dollar.


The rupee tumbled to a new low against the dollar in the midst of an increase in crude oil price

Wall Street saw a sharp fall at its closing in a broad sell-off. Consumers' worries over recession have sparked up...

Stock Market

Wall Street Lose Balance after recession strikes growth fear among consumers’

Soaring inflation may be pushing the US economy into a deep recession. Last week's 0.75% interest rate hike by the Federal Reserve...

Stock Market

Inflation ringing the recession bell - Mohammed Shaheen


27 Dec 2021

Fourth COVID-19 Vaccine Shot is Already in Trial at Israeli Hospital

The Index Today

Sheba Medical Center, a major Israeli hospital announced on Sunday that they will begin administering a fourth COVID-19 vaccine shot to 150 staffs on Monday in a trial aimed at gauging whether a second booster is necessary nationwide.

Sheba Medical Center near Tel Aviv said its trial would shed light on the effectiveness of a fourth dose and help the decision-makers set health policy in Israel and other countries.

Israel already reported 1,118 confirmed cases of the fast-spreading Omicron variant, with the number of people infected by it doubling every two days.

A Health Ministry panel of experts has recommended offering a fourth dose of the Pfizer/BioNTech vaccine to Israelis aged 60 and over who received a booster shot at least four months ago.

Sheba Medical Center did not say how long its trial would last.

Gili Regev-Yochay, the study's director said, "We will examine the fourth dose's effect on the level of antibodies and morbidity and we will gauge its safety, we will understand whether it is worthwhile to administer a fourth shot, and to whom."

The 150 medical workers taking part in the trial, had already received Health Ministry approval and got booster shots no later than Aug 20.

©Photo: Yonatan Sindel/Pool via AP

Clay pottery with table linens
bottom of page